Informa Connect, a vital business unit of the Informa Group, is a global leader in B2B services, specializing in industry connections and market insights. With a portfolio of over 550 international events and brands, Informa Connect serves a diverse range of sectors, including healthcare, construction, fashion, and food and beverage. The mission of Informa Connect is to create and sustain global professional communities, fostering innovation and collaboration across industries.

The Antibody Engineering and Therapeutics series, hosted by Informa Connect, is a premier global event dedicated to advancing the field of antibody-based therapeutics. This annual conference brings together leading scientists, researchers, and industry experts to share the latest breakthroughs, discuss emerging trends, and explore new frontiers in antibody engineering and therapeutic development.

Antibody Engineering & Therapeutics Europe will convene over 350 leading researchers, scientists, and industry professionals to explore the latest advancements in antibody engineering and their therapeutic applications. The conference will cover a wide array of topics, including:

- Emerging In Vitro Approaches to Antibody Discovery
- Advanced In Vivo Antibody Discovery
- Enhanced Therapeutic Function Through Fc Engineering
- Multi-specific Engineering
- Agonist Antibodies, Co-stimulation & Combination Therapy
- Beyond IgG: Next-gen Therapeutic Scaffolds & Antibody Formats
- Therapeutic Antibody Applications Beyond Oncology
- Antibodies for Autoimmune Disease
- Innovations with Antibody Payloads

The sister-conference to the San Diego meeting, Antibody Engineering & Therapeutics US, the European counterpart promises to deliver critical insights in an environment designed to cultivate discussions that will propel the industry forward. With a programme created in conjunction with The Antibody Society, the mix of academia and industry enables a knowledge-hub unlike any other.